Carasent

Q2 2025 highlights

• Net sales amounted to MSEK 82.9 (65.9), representing a net sales growth of 26%.
• Organic growth was 13% while net acquisitions and divestments in the last twelve months accounted for MSEK 9.1 or 14 percentage points of the growth.
• Recurring revenues amounted to MSEK 76.1 (60.8), with organic recurring revenue growth of 13%.
• EBITDA amounted to MSEK 12.1 (7.8), representing an EBITDA margin of 15% (12%).
• Adjusted EBITDA margin was 15% (16%).
• Operating result, EBIT, amounted to MSEK -3.7 (-7.6).
• Adjusted EBITDAC margin was 3% (-2%).
• Cash flow from operating activities amounted to MSEK 12.8 (14.1).
• Net income amounted to MSEK -5.5 (-5.7).
• Earnings per share, before and after dilution, amounted to SEK -0.08 (0.08).

H1 2025 highlights

• Net sales amounted to MSEK 168.1 (132.0), representing a net sales growth of 27%.
• Organic growth was 14% while net acquisitions and divestments in the last twelve months accounted for SEK 18.8 million or 14 percentage points of the growth.
• Recurring revenues amounted to MSEK 153.3 (121.7) , with organic recurring revenue growth of 14%.
• EBITDA amounted to MSEK 26.0 (14.0), representing an EBITDA margin of 15% (11%).
• Adjusted EBITDA margin was 15% (14%).
• Operating result, EBIT, amounted to MSEK -5.6 (-21.9).
• Adjusted EBITDAC margin was 4% (-5%).
• Cash flow from operating activities amounted to MSEK 17.4 (26.9).
• Net income amounted to MSEK -8.5 (-16.0).
• Earnings per share, before and after dilution, amounted to SEK -0.12 (-0.22).

The results will be presented as a webcast at 8:00 CET today. If you wish to participate via webcast please use the link below.
https://carasent.events.inderes.com/q2-report-2025

For further details please contact:
Daniel Öhman, CEO Tel: +46 70-855 37 07, or
Svein Martin Bjørnstad, CFO Tel: +47 979 69 493